Clinical trial
Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01)
NCT02710955 is registered in ClinicalTrials.gov with United Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01)
- Lead sponsor
- United Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2016
- Completion date
- April 12, 2017
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.